2021
DOI: 10.1096/fj.202100013r
|View full text |Cite|
|
Sign up to set email alerts
|

Activated Galectin‐9/Tim3 promotes Treg and suppresses Th1 effector function in chronic lymphocytic leukemia

Abstract: Tim‐3 is a negative immunoregulator in anti‐tumor response, but its mechanism in chronic lymphocytic leukemia (CLL) is not yet clear. The aim of this study was to understand the role of Galectin‐9/Tim‐3 signaling pathway in the regulation of CD4+ T cell subsets in CLL patients. Flow cytometry results showed that the number of Treg cells obviously increased, and there was a significant Treg/Th17 imbalance in CLL patients. In addition, Tim‐3 overexpressed on the surface of Th1 and Treg cells in CLL patients. The… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
35
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 36 publications
(37 citation statements)
references
References 35 publications
2
35
0
Order By: Relevance
“…Here, we selectively isolated human naive CD4 + T cells and treated them with Gal-9, to assess the ability of Gal-9 to drive human T cell differentiation. In line with previous studies (49,50), we found that Gal-9 alone was effective at inducing Treg differentiation in a dose-dependent manner. Moreover, there was also a dose-dependent increase in IL-10 levels in supernatants from Gal-9 treated T cell cultures, suggesting a specific role for Gal-9 in inducing Treg functions (i.e., IL-10 production).…”
Section: Discussionsupporting
confidence: 92%
“…Here, we selectively isolated human naive CD4 + T cells and treated them with Gal-9, to assess the ability of Gal-9 to drive human T cell differentiation. In line with previous studies (49,50), we found that Gal-9 alone was effective at inducing Treg differentiation in a dose-dependent manner. Moreover, there was also a dose-dependent increase in IL-10 levels in supernatants from Gal-9 treated T cell cultures, suggesting a specific role for Gal-9 in inducing Treg functions (i.e., IL-10 production).…”
Section: Discussionsupporting
confidence: 92%
“…Therefore, in aortic aneurysms, MIF from T cells plays a role in promoting the transformation of VSMCs to macrophage-like VSMCs, while MIF from VSMCs recruits immune cells (especially B cells) into aortic aneurysms. As previous studies showed that galectin 9–CD44 interaction is in favor of stability and function of adaptive regulatory T cells ( 29 ), galectin 9–CD45 inhibits naive B-cell activation ( 30 ), and can inhibit CD4 + T-cell expansion and suppress Th1 effector function ( 31 ). Hence, we speculate that macrophage-like VSMCs and macrophages both exert an immunomodulatory capacity through the galectin signaling pathway.…”
Section: Discussionmentioning
confidence: 99%
“…Tregs further inhibit CD4 + T H cell proliferation and function by secreting cytokines such as IL-10 and inhibiting IL-2 availability for CD4 + T H cells (34,35). The balance between T H 1 and Treg cells has drawn great attention in cancer (36), various inflammatory diseases (37,38), and autoimmunity diseases (39). Treg accumulation and T H 1 cell downregulation are also necessary for the convalescence of crescentic glomerulonephritis (40).…”
Section: Discussionmentioning
confidence: 99%